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OBJECTIVE—Interactions between genetic and environmental
factors lead to immune dysregulation causing type 1 diabetes and
other autoimmune disorders. Recently, many common genetic
variants have been associated with type 1 diabetes risk, but each
has modest individual effects. Familial clustering of type 1 diabetes
has not been explained fully and could arise from many factors,
including undetected genetic variation and gene interactions.
RESEARCH DESIGN AND METHODS—To address this issue,
the Type 1 Diabetes Genetics Consortium recruited 3,892 families,
including 4,422 affected sib-pairs. After genotyping 6,090 markers,
linkage analyses of these families were performed, using a novel
method and taking into account factors such as genotype at known
susceptibility loci.
RESULTS—Evidence for linkage was robust at the HLA and INS
loci, with logarithm of odds (LOD) scores of 398.6 and 5.5,
respectively. There was suggestive support for ﬁve other loci.
Stratiﬁcation by other risk factors (including HLA and age at di-
agnosis) identiﬁed one convincing region on chromosome 6q14
showing linkage in male subjects (corrected LOD = 4.49; replica-
tion P = 0.0002), a locus on chromosome 19q in HLA identical
siblings (replication P = 0.006), and four other suggestive loci.
CONCLUSIONS—This is the largest linkage study reported for
any disease. Our data indicate there are no major type 1 diabetes
subtypes deﬁnable by linkage analyses; susceptibility is caused
by actions of HLA and an apparently random selection from
a large number of modest-effect loci; and apart from HLA and
INS, there is no important susceptibility factor discoverable by
linkage methods. Diabetes 60:1030–1040, 2011
T
ype 1 diabetes is an autoimmune disease in
which the insulin-producing b-cells are destroyed.
The defective immune mechanisms in type 1 di-
abetes have not been identiﬁed, although clearly
both genes and environmental factors contribute to risk
(1,2). Many studies have been performed on the genetics of
type 1 diabetes, and identiﬁcation of the risk genes is on-
going. The Type 1 Diabetes Genetics Consortium (T1DGC)
was established in response to the need to identify type 1
diabetes risk genes (3).
The T1DGC has assembled DNA, sera, cell lines, and data
from 17,129 individuals in 3,892 affected–sib-pair (ASP)
families, representing the largest family collection in any
immune-mediated disease. Using these resources, the T1DGC
performed smaller genome-wide linkage studies (4,5) and
association studies, ﬁnding 21 new loci (6). In addition, the
T1DGC conducted the most detailed investigation of the HLA
complex in disease, characterizing over 3,000 single nucleo-
tide polymorphisms (SNPs), and independently tested all
previously reported type 1 diabetes susceptibility genes (7,8;
a n da s s o c i a t e ds p e c i a lr e p o r t s ) .
From these and other studies, over 50 loci have been
identiﬁed that affect the risk of developing type 1 diabetes
(6) (www.t1dbase.org). Foremost among these is the HLA
complex, which is long recognized as the most important
risk factor in type 1 diabetes and other immune diseases.
The second locus identiﬁed was INS, but this and other
non-HLA loci have relatively minor risk effects comparable
to loci mapped in other common diseases, with risk esti-
mates typically between 1.05 and 2.0 (6).
Despite the T1DGC’s success, not all the estimated fa-
milial heritability for type 1 diabetes has been found. Twin
studies suggest ~80% of clustering is a result of sharing of
susceptibility alleles at multiple loci. This issue of “missing
heritability” also arises in other complex genetic diseases
(9). A number of other issues pertaining to type 1 diabetes
remain unresolved. For example, can it be subdivided into
disease subtypes with different genetic etiology? Can we
identify major genetic interactions in susceptibility? Are
there loci with multiple rare risk alleles that may have
gone undetected in association studies? Does genomic
instability in the form of structural variants play a role?
Motivated by these issues, we report here the genotyp-
ing of the ﬁnal 1,583 T1DGC ASPs and perform linkage
analyses on a total of 3,892 families and 17,129 individuals.
The T1DGC family collection provides 80% power to
search for loci undetectable by genome-wide association
SNP scanning with effects of the same magnitude as the
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ORIGINAL ARTICLEinsulin gene with allelic odds ratio of ~2 and an allele
frequency of 0.3. If there is residual “missing heritability”
(i.e., loci that were not found by the SNP studies), this
large dataset is a valuable resource to search for it. In this
report, we describe a linkage search for genetic inter-
actions in type 1 diabetes.
RESEARCH DESIGN AND METHODS
This study was approved by review boards of all contributing institutions, and
appropriate informed consent was obtained from families. Inclusion criteria
have been reported (3–5). Brieﬂy, a family must contain at least one affected
sib-pair; “affected” indicates a type 1 diabetes diagnosis before the age of
35 years with insulin required within 6 months of diagnosis. Samples from
1,505 newly recruited families, as well as previously untyped members from
84 families recruited earlier (4,5), were available for genotyping. Families
came from four T1DGC networks: Asia-Paciﬁc( n = 116 families), Europe (n =
628), North America (n = 807), and the U.K. (n = 38). Of samples sent for
genotyping, 1,396 (88%) families had two affected full siblings, 63 (4.0%)
families had three, and 3 (0.2%) families had four or more. Four pedigrees also
provided affected half-siblings. The remaining 117 (7.4%) families included
samples from other family members that were unavailable for genotyping for
the previously reported cohorts; thus, they were available for the analyses of
the total T1DGC dataset. Both parents were available for 914 families, whereas
397 families consisted of a single parent.
Genotyping. Genotyping of 6,090 SNPs with an average 0.58-cM genome-wide
spacing was carried out at the Center for Inherited Disease Research using the
Illumina Human Linkage-12 Beadchip. Karyotype locations of SNPs were from
the T1DBase.
Pedigree checking. Genotype data were evaluated for Mendelian errors using
PedCheck (10) and PREST (11). Merlin’s Pedwipe function (12) identiﬁed and
resolved inconsistencies within families. Five families (seven ASPs) were re-
moved because of nonresolvable family issues. Another 19 families (19 ASPs)
were excluded by Merlin. A total of 1,487 families passed all quality-control
ﬁlters and were analyzed as T1DGC cohort 3. There were non-ASP samples
from 78 previously incomplete families (4,5). Combined with the previously
reported cohorts (4,5), there was a total of 4,422 ASPs from 3,892 families.
Pedigree stratiﬁcation. Sib-pairs were selected for stratiﬁcation analyses
using SibShipper (www.sysgen.org.au), a suite of tools for pedigree manipu-
lation, and PLINK (13).
Statistical analyses. Nonparametric linkage analyses were performed using
the linear NPL model (14) implemented in Merlin (12), which accounted for
linkage disequilibrium between SNPs by selecting r
2 . 0.10 to deﬁne SNP
FIG. 1. Genome-wide linkage analyses of the ﬁnal T1DGC cohort. Nonparametric linkage calculations of 6,090 SNPs segregating in 1,487 new
affected sib-pair families were performed using Merlin (12). Kong and Cox LOD scores (14) are shown for each chromosome. The peak LOD on
chromosome 6 was over 130, but the scale is truncated to show linkage scores for other loci.
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Proﬁles of logarithm of odds (LOD) scores were compared statistically by
treating scores as correlated time-series, with chromosome position as “time.”
The automated expert modeler facility in SPSS 17.0 was used to obtain the
optimal parsimonious time-series model with approximately independent
residuals. For both proﬁles, this produced a model in which the difference
between each successive pair of scores regressed linearly on the preceding
difference (i.e., a differenced ﬁrst-order autoregressive model). Peaks in the
original proﬁles would manifest as increased variation in the residuals at
positions spanning the peak. The absolute values of residuals were then com-
pared across sections of the chromosome via ANOVA. More details are pro-
vided below.
RESULTS
Linkage results of the third T1DGC cohort. Each
member of the 1,583 newly recruited T1DGC families was
genotyped at 6,090 SNPs genome-wide. Nonparametric
linkage analysis was performed; results are summarized in
Fig. 1 and Table 1. Peak linkage was observed on
chromosome 6p21.3, the location of the HLA class II
genes contributing the main type 1 diabetes risk. Apart
from three other peaks on chromosome 6, no other
region yielded genome-wide signiﬁcant linkage (i.e.,
LOD .3.6). The three peaks on chromosome 6 were at
SNPs rs2296412 (chromosome 6q14.2 and 92.7 cM),
rs6934871 (chromosome 6q15 and 95.7 cM), and rs873460
(chromosome 6q22.31 and 123.1 cM); these chromosomes
had LOD scores (unadjusted for HLA linkage) of 10.71,
10.61, and 3.78, respectively (see Table 1 for corrected LOD
scores).
The highest linkage score on other chromosomes was
2.74 at chromosome 11p15, the location of INS. The only
other locus with an LOD score above the suggestive link-
age threshold of 2.2 was on chromosome 8p12, with peak
linkage at SNP rs1836851. This chromosome region has
not been implicated in previous genome-wide linkage or
association scans.
Complete T1DGC linkage results. The total T1DGC
collection of 4,422 ASPs constitutes the largest linkage
study conducted for any disease. Results from the linkage
analysis of the total dataset are presented in Fig. 2, and
a summary is shown in Table 1. As expected, the evidence
for linkage to the HLA region increased, with a peak LOD
score of 398.6 (Fig. 2B), reinforcing the importance of this
complex in the etiology of type 1 diabetes.
Chromosome 6 linkage was further examined, taking
into account the HLA linkage that may mask other sus-
ceptibility loci on this chromosome. One way to account
for this is by calculating the expected LOD (ELOD) based
on the decay of linkage from HLA, assuming a Kosambi
map function (i.e., independent crossovers). Region(s)
showing linkage signiﬁcantly higher than the ELOD may
contain gene(s) that affect type 1 diabetes risk. These
analyses were carried out as previously described (4,5).
This analysis showed additional linkage signals on chro-
mosome 6q (Fig. 2B; Table 1), which overlapped with the
previously reported locus IDDM15 (4,5,15).
The second locus that achieved genome-wide signiﬁ-
cance was the IDDM2 (INS) locus on chromosome 11p15,
with an LOD of 5.53. A locus on chromosome 19q almost
reached genome-wide signiﬁcance (LOD = 3.3). Apart from
these, across the rest of the genome there was no increase
in the evidence for linkage at loci that previously (4,5) had
suggestive scores. Support for some loci was reduced (e.g.,
the chromosome 2q locus including the CTLA4 gene [4,5]
fell from an LOD of 3.35 to an LOD of 3.11). There were
two new regions with suggestive support levels deﬁned
in this study: the evidence for linkage at chromosomes
2q13 and 8q21 increased to LODs of ~2.7 (SNP rs1439287
at 111.6 Mb and SNP rs1902866 at 87.8 Mb). No signiﬁ-
cantly associated loci had been mapped to these regions
(6).
Stratiﬁcation by HLA sharing status. Previously, sup-
port for some non-HLA type 1 diabetes susceptibility genes
was increased after stratiﬁcation of ASPs according to
biologically relevant criteria, such as HLA genotype or sex
(16–20). We tested whether subgroup analyses such as
these would provide stronger evidence of linkage. Our
strategy was to conduct these tests in the previously
TABLE 1
Suggestive (LOD .2.2) and signiﬁcant (LOD .3.6) loci from genome linkage scans of the T1DGC family collections
Families Position (cM) LOD P LOD-1 support interval
Reported in T1DGC
sets 1 and 2 (4,5)
T1DGC set 3
Chromosomes
6p21 52.5 135.7 51.0–52.5 Yes
6q14 92.7 5.1* 90.7–93.3 Yes
6q15 95.7 6.2* 93.3–98.1 Yes
6q22 123.1 3.23* 0.00006 120.5–126.9 No
8p12 52.7 2.4 0.0004 48.8–60.9 No
11p15 1.05 2.74 0.0003 0–4.7 Yes
Sets 1, 2, and 3
Chromosomes
2q13 123.8 2.68 0.0002 120.3–126.8 No
2q31 194.2 3.11 0.00008 191.8–193.8 Yes
6p21 52.0 398.6 51.5–52.5 Yes
8q21 95.5 2.65 0.0002 93.5–101.5 No
11p15 2.5 5.53 0–5.0 Yes
19q13 58.0 3.30 0.00005 54.5–63.5 Yes
Summary of linkage analyses for the third and ﬁnal set of T1DGC families. Positions of LOD score peaks are shown for the chromosome band
(taken from www.t1dbase.org for the nearest SNP) and cM position. P values shown for LODs ,5. *LOD scores on chromosome 6q were
adjusted for HLA linkage by subtracting the ELOD (see text). Peaks were deﬁned as points at least 1 LOD unit above the surrounding linkage
plot; the additional families in the combined dataset obscured the separable peaks observed on chromosomes 6q14 and 6q15 in set 3 alone.
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signiﬁcant ﬁndings in the ﬁnal (set 3) T1DGC cohort.
Taking into account multiple testing, a threshold for sug-
gestive linkage was set at an LOD = 3.28.
The ﬁrst stratiﬁcation was HLA linkage status. Siblings
sharing two HLA haplotypes that were identical by descent
(IBD) formed one group. The second stratiﬁcation group
(HLA non-IBD) consisted of siblings sharing one or zero
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FIG. 2. Evidence of linkage from the entire T1DGC ASP family collection. A: Pedigree ﬁles were merged from the latest set of T1DGC families and
those reported earlier (4,5) (which are shown in red). LOD scores for the entire dataset were calculated as described in Fig. 1 and shown in blue.
The scale is truncated at 4, so it does not indicate the height of the peaks on chromosome 6 (~400) (see B) and 11 (~5). B: Linkage of chromosome
6 markers in the T1DGC family collection. LOD scores were calculated for the complete T1DGC family collection (solid green line) and compared
with the cohort 3 families (dashed purple line). In addition, LOD scores were calculated correcting for linkage to HLA: the ELOD score based on
decay of linkage from HLA is shown as a dashed blue line and ELOD + 3.6 as a dotted red line. The increase in observed LOD above ELOD in the
region ~90–100 cM is consistent with additional type 1 diabetes susceptibility gene(s) mapping to this region.
G. MORAHAN AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, MARCH 2011 1033haplotypes by descent (but note that these siblings may be
identical by state for particular HLA class I or class II
alleles). Genome-wide linkage analyses on these two sets
showed no locus with an LOD .3.28 (Fig. 3). However,
there was some (uncorrected) evidence of two loci con-
tributing to type 1 diabetes on chromosome 19, each of
which showed linkage in different sib-pair sets depending
on the HLA sharing status (Fig. 4). These peaks were at
rs1548506 (LOD = 2.87; HLA IBD ASPs) and at rs966591
(LOD = 3.03; HLA non-IBD ASPs). To test the statistical
differences in linkage between stratiﬁed sets, we applied
a novel approach based on time-series analysis. Proﬁle
shapes were reﬂected empirically in changing variability of
residuals from ﬁtted-differenced autoregressive models.
Chromosome 19 was then divided approximately into
thirds, and the relative changes in variation in the residuals
between the two strata across these regions were assessed
through the interaction term in two-way ANOVA. Square
roots of the absolute values of the residuals were used.
The overall analysis (P , 10
215) indicated different linkage
proﬁles. In particular, variation was higher in non-IBD than
IBD ASPs at 19p loci (P = 2.0 3 10
25), with the converse at
19q loci (P = 1.3 3 10
212) (Wilcoxon tests) (Fig. 4B).
Stratiﬁcation by HLA-DRB1 status. ASPs were strati-
ﬁed according to HLA-DRB1 haplotype status. Pairs of
siblings were selected using the following criteria: both with
DRB1*03 but not DRB1*04 alleles (“DR3/x”); both with
DRB1*04 but not DRB1*03 alleles (DR4/x); both heterozy-
gous for HLA-DRB1 high-risk alleles (i.e., DRB1*03/04;
DR3/4); and neither affected sibling having DRB1*03 nor
DRB1*04 (DRx/x). Linkage analyses were performed on
each group. Apart from HLA, no locus exceeded our
threshold of corrected LOD = 3.28. Only one locus exhibited
uncorrected LOD .3( ﬁgure not shown): this had an LOD of
3.18 in the DR3/4 ASP group at the SNP rs424074, located
at 99 cM on chromosome 16q23.1.
FIG. 3. Genome-wide linkage analysis of siblings sharing 2 (IBD) or 1/0 (non-IBD) HLA haplotypes IBD. Pedigree ﬁles of T1DGC sets 1 and 2 were
constructed using SibShipper (www.sysgen.org.au) from ASPs that shared 2 HLA haplotypes IBD and from the remaining set of siblings that shared
one or zero alleles IBD (for convenience, the latter set is referred to as non-IBD). LOD scores were calculated for each set as described in Fig. 1.
The scores for the IBD ASPs are shown in red and non-IBD ASPs are shown in blue.
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have shown that INS variants cause differences in insulin
gene expression and are signiﬁcantly associated with type
1 diabetes susceptibility (21,22). We tested whether these
variants preferentially interacted with other loci by strati-
fying ASPs by INS genotypes. Two sets of ASPs were
studied: those homozygous for the A allele at the 223/HphI
site (rs689) and those who carried at least one copy of the
T allele. The 223/HphI “A” allele shows almost complete
linkage disequilibrium with type 1 diabetes–associated INS
VNTR class I alleles (23). Linkage analysis of the two sets
revealed a novel locus in the AA homozygous siblings, with
a maximum LOD of 4.19 at 83.5 cM near rs6988179 on
chromosome 8q13.3 (Supplementary Fig. 1; Table 2). ASPs
who had at least one T allele showed an apparent linkage
peak on chromosome 6q13 (uncorrected LOD = 4.83 near
rs1416546 at 87 cM).
Stratiﬁcation by sex. Type 1 diabetes, unlike other
autoimmune diseases, affects male and female subjects
approximately equally. Previous studies (19,20) have sug-
gested susceptibility loci that preferentially affected one
sex. We examined this issue on a genome-wide basis.
Families were selected in which only male or only female
ASPs were affected. There was no difference in LOD
scores at HLA for the two sets stratiﬁed by sex (female
ASPs: LOD = 62.37; male ASPs: LOD = 62.11). Apart from
linkage to HLA, there was no other signiﬁcant linkage
in the female-only ASPs set. In the male-only ASPs, ﬁve
loci yielded LOD scores .3: three loci were mapped to
chromosome 6q and the other two loci resided on chro-
mosomes 11p and 19p (Supplementary Fig. 2). Markers
at these peaks were rs1398576 (chromosome 6q14.1;
LOD = 5.57), rs1158747 (chromosome 6q21; LOD =
3.46), rs1569741 (chromosome 6q22.32; LOD = 3.91; not
FIG. 4. Linkage analysis of HLA IBD and HLA non-IBD sib-pairs for markers on chromosome 19 of ASPs from T1DGC sets 1 and 2. A: LOD scores on
chromosome 19 are shown for the total dataset (black), HLA IBD siblings (red), and HLA non-IBD siblings (blue). Stratiﬁcation according to HLA
sharing indicates two different linkage peaks on this chromosome. B: ASPs who were HLA IBD (red boxes) or non-IBD (blue boxes) were com-
pared for differences on chromosomes 19p (position <40 cM), 19q (40–80 cM), and 19qtel (>80 cM) via residuals from differenced autoregressive
models as described in RESEARCH DESIGN AND METHODS. Relative variation in residuals across the chromosome differed between subgroups (P < 10
215),
suggesting differing linkage proﬁles. P values for differences between HLA IBD and non-IBD ASPs for the three regions of chromosome 19 are 19p,
P = 0.00002; 19q, P =1 . 33 10
212; and 19tel, P = 0.06. Boxes represent the mid-50% of values; horizontal lines indicate means.
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rs1688128 (chromosome 19p13.3; LOD = 3.22), respectively.
Stratiﬁcation by age at diagnosis. Type 1 diabetes
usually has an onset before puberty, but a signiﬁcant
proportion of cases are diagnosed at later ages. It has been
proposed that there may be a different genetic basis for
these age effects (24). We were able to perform a genome
scan on 304 ASPs who were each diagnosed after 15 years
of age. In addition, we analyzed 279 ASPs in which each
sibling was diagnosed before the age of 5 years. Only
one locus approaching suggestive signiﬁcance was found.
This one locus had an LOD = 3.13 near rs38993 on
chromosome 7q36.2 in the older-onset ASPs (Supple-
mentary Fig. 3). This is a novel region for type 1 diabetes
susceptibility.
Testing chromosome 6 loci with correction for HLA
linkage. Two stratiﬁed sets (male subjects and INS AA
genotype–affected sib-pairs) showed apparent linkage on
chromosome 6q, to which the IDDM5, IDDM8, and
IDDM15 loci were previously mapped (15,18). ELOD
scores were calculated as described above for the strati-
ﬁed sets, showing potential linkage (male sib-pairs; and
INS T allele-bearing sib-pairs) and, for comparison, the
complementary stratiﬁed set (female sib-pairs; INS AA
genotype sib-pairs). The results show that the respective
peaks met or exceeded ELOD + 3.6, indicating additional
evidence for linkage in the relevant stratiﬁed sets (Fig. 5).
These peaks map to different locations. Thus, the IDDM15
locus may reﬂect a combination of two (or more) loci on
chromosome 6q that interact with different susceptibility
loci. Candidates for these loci include the four conﬁrmed
genome-wide association study (GWAS) SNP-associated
regions on chromosome 6q (6).
Testing stratiﬁcation loci in T1DGC set 3 families.
Families from the ﬁnal T1DGC cohort were stratiﬁed as
above, but the analyses were only performed for the loci
with LOD .3 or with signiﬁcant differences between
stratiﬁed sets, as discussed above. Results of these con-
ﬁrmation tests are summarized in Table 2. Three stratiﬁed
loci could be conﬁrmed unequivocally: the locus on chro-
mosome 19q for HLA IBD siblings and the loci on chro-
mosome 6q13/14 for male and INS “Tx” siblings; the same
gene may be responsible for these chromosome 6q loci.
Another two loci had signiﬁcant scores on the same
chromosome but outside the region within one LOD unit of
the peak (i.e., LOD-1): 8q13 for INS AA genotype siblings
and 7q36 for older age-of-onset siblings. In complex dis-
eases, the location of causative genes may be displaced
compared with both the peak and LOD-1 interval (25);
therefore, these regions warrant further investigation.
The correlation with GWAS-identiﬁed loci also is pre-
sented in Table 2. The following are ﬁve of the stratiﬁed
loci that had (corrected) suggestive LOD scores in regions
that gave signiﬁcant results in the T1DGC GWAS (6):
PRKD2, CTRB2, CENPW (formerly C6orf173), INS, and
C19orf19. Association of these SNPs listed in Table 2
could be followed-up in future studies of subsets of type 1
diabetes cases.
TABLE 2
Test for replication of stratiﬁed loci in T1DGC set 3 families
Stratiﬁcation cM LOD P Corrected LOD* LOD-1 interval P in set 3 GWAS SNP
HLA IBD
Chromosome
19q13 59.0 2.83 0.0002 1.75 54.0–64.5 0.006 PRKD2
HLA MIS
Chromosome
19p 23.0 3.04 0.00009 1.98 18.0–27.5 NS —
HLA DR3/4
Chromosome
16q23 99.1 3.18 0.00006 2.10 96.0–110.0 0.06 CTRB2
INS†
Chromosomes
6q13 87.0 3.34‡ 0.00004 2.26 81.5–90 0.004
8q13 83.5 4.19 0.00001 3.11 80.0–88.0 NS§ —
Male subjects 90.0 2.90‡ 0.00013 1.59 86.5–91.5 0.0002
Chromosomes
6q14
6q21 116.0 3.10‡ 0.00008 2.02 109.0–118.5 0.03 —
6q22 127.0 3.76‡ 0.00002 2.68 120.0–130.0 0.09 CENPW
11p15 2.5 3.18 0.00007 2.10 0–7.0 NS INS
19p13 9.5 3.22 0.00006 2.14 5.0–13.5 NS C19orf19
AAD
Chromosomes
7q36 172.5 3.13 0.00009 2.05 163.5–179.5 NS§ —
Loci showing LOD scores .3 from the stratiﬁed analyses and those showing signiﬁcant differences between stratiﬁed sets (Fig. 4) were tested
in the third collection of T1DGC families. Pedigree ﬁles of the relevant chromosomes from the third T1DGC cohort were stratiﬁed according
to criteria presented above, and P values were calculated by Merlin. Genome-wide association scan SNPs that showed signiﬁcant association
with type 1 diabetes in or near to these regions are shown as candidates for these loci. NS, not signiﬁcant; P . 0.1. *Final corrected LODs were
obtained by subtracting 1.08, the log of the number of stratiﬁcation tests (n = 12) (32). †Note that INS stratiﬁcation shows that the 6q13 score
shows a signal from siblings who each have at least one protective T allele, whereas the 8q13 signal comes from those homozygous AA (i.e.,
the INS risk allele). We interpret this as suggesting that the chromosome 6q locus is able to overcome the protective affect of the INS T allele.
In contrast, the 8q13 locus may interact with the INS susceptibility alleles to increase disease risk. ‡LOD scores for chromosome 6q loci were
adjusted for residual HLA linkage by subtracting ELOD (see text). §Markers outside the LOD-1 interval gave P values of 0.003 and 0.01,
respectively, in appropriately stratiﬁed set 3 families.
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whether any of the linkage peaks observed in the stratiﬁed
sets could be explained by SNPs associated with type 1
diabetes susceptibility in the T1DGC GWAS study (6),
families were stratiﬁed according to criteria above and
tested by the transmission disequilibrium test (TDT).
Twenty SNPs were signiﬁcantly associated in the overall
dataset (uncorrected P values ,10
23) (Table 3). However,
for the linked regions listed in Tables 1 and 2, only regions
6p21, 11p15, 19q13, and 2q33 contained SNPs showing
associations with type 1 diabetes by analysis of allele
transmissions (Table 3). There were signiﬁcant differences
in transmission for the HLA SNPs between the HLA iden-
tical and mismatched ASP sets, conﬁrming a similar earlier
analysis of 3,000 HLA SNPs in the T1DGC families (26). There
also was an apparent bias in transmission of the HLA-DQA1
SNP in affected brothers. However, there were no signiﬁ-
cant differences in the non-HLA SNPs between any of the
sets stratiﬁed by the other criteria (sex, INS genotype, or
age of diagnosis).
DISCUSSION
Comparison with previous type 1 diabetes linkage
scans. The results from the third and ﬁnal T1DGC family
collection include strong conﬁrmation of linkage to the
HLA complex (LOD = 135.7) and suggestive linkage to INS.
Additional peaks on chromosome 6q also were evident.
Three IDDM loci have been mapped to chromosome 6q
(6,15,16,18). Part of the linkage signal detected on chro-
mosome 6q may reﬂect these or the 6q GWAS loci,
including TAGAP SNPs, which showed evidence of asso-
ciation in these families (Table 3). In addition, there was
a suggestive linkage peak on chromosome 8p12, a region
not previously reported.
Considering the entire T1DGC family collection of 4,422
ASPs, there was a total of six loci with LOD scores over
the suggestive threshold of 2.2. Aside from HLA and INS,
the combined dataset provided the 19q13 locus with an
increased score of 3.3. However, a previously reported
locus including 2q31 and CTLA4 had a reduced, though
still suggestive (3.11), LOD score in the ﬁnal dataset. This
chromosomal region contains four associated loci, in-
cluding CTLA4; these and possibly other undetected loci
could have accumulated effects to generate this linkage
signal.
In the combined dataset, an additional locus on 6q22 at
~123 Mb reached nominal signiﬁcance (unadjusted LOD =
3.47); this may be attributed to the effect of the GWAS
SNP near CENPW (6) and/or other associated SNPs in
the region, as well as IDDM15.T h eIDDM15 locus was
previously mapped with a peak at ~102 Mb on 6q, but its
location is difﬁcult to deﬁne because of the very large HLA
signal, residual linkage to this region, male/female re-
combination differences, and because this locus may re-
ﬂect multiple susceptibility genes indicated by the GWAS
chromosome 6q SNPs (6).
Comparison with GWAS data. The ﬁndings from these
linkage studies, summarized in Table 3, contrast with those
from the T1DGC GWAS (6) in which over 50 type 1 di-
abetes risk genes were deﬁned. One reason for these
contrasting results could be that familial clustering of type
1 diabetes is predominantly attributed to HLA-linked genes
with little inﬂuence of non-HLA genes. This is supported by
evidence that, although non-HLA type 1 diabetes risk loci
identiﬁed in GWAS could be replicated in ASP families, the
FIG. 5. Chromosome 6 analyses, with correction for HLA linkage. ASP families from T1DGC sets 1 and 2 stratiﬁed on the basis of sex (upper
panels: left, female ASPs; right, male ASPs) or INS genotype (lower panel: left, INS homozygous for the A genotype; right, at least one copy of the
protective T allele). Observed LOD scores are shown in solid green lines. ELOD scores (dashed blue lines) are shown correcting for HLA linkage.
The ELOD + 3.6 score (dotted red lines) indicates the threshold for linkage of a type 1 diabetes risk locus independent of HLA.
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fect sizes (6). Lack of signiﬁcant evidence for linkage in
the regions corresponding to GWAS-detected associated
SNPs was expected as a consequence of the small in-
dividual contribution of these loci and their often high al-
lele frequency in these reported associations, so that
siblings could have a genotype identical by state rather
than IBD, thereby not showing linkage and not increasing
the observed LOD scores. In addition, the sporadic cases
for the GWAS (6) were drawn from only two countries
(U.K. and U.S.), whereas the T1DGC families were recruited
from many different countries and diverse recruitment
networks (Asia-Paciﬁc, Europe, and North America) that
differ markedly in environmental inﬂuences that may affect
penetrance of susceptibility alleles. Thus, the increased
genetic and environmental heterogeneity could limit the
ability to detect genes that may affect risk in some pop-
ulations but not others. The non-HLA loci that survived the
total analyses may have done so because they had con-
sistent, albeit weak, effects across cohorts, rather than
showing signiﬁcant linkage in individual cohorts.
Genetic heterogeneity and epistasis. Another reason
for the scant returns from this study could be disease
heterogeneity, which could be increased by the require-
ment of worldwide recruitment of families to achieve
sufﬁcient statistical power. If there were multiple type 1
diabetes subtypes involving different genetic pathways,
then the numbers of sib-pairs sharing haplotypes at rele-
vant genes would be swamped by the remaining siblings
with Mendelian-sharing ratios. Support for a notion of
different genetically determined type 1 diabetes subtypes
comes from the variation seen in disease, with some fami-
lies having an earlier onset, and from studies that suggest
that the increase in type 1 diabetes in recent decades is
associated with lower risk HLA alleles (24). To address this
issue, we compared sib-pairs selected for relevant criteria
that have been shown previously to increase linkage evi-
dence for particular loci (16–20). Although seven loci were
implicated using this approach, the LOD scores for these
could not support a hypothesis that they played a major role
even in the type 1 diabetes subtype studied.
We conclude that there are no major genetically dis-
cernible type 1 diabetes subtypes deﬁned by interaction of
HLA and non-HLA genes. Furthermore, it appears that
there are no major epistatic interactions in type 1 diabetes,
at least based on interactions of individual non-HLA genes
with HLA, INS, and sex-speciﬁc factors. This is consistent
with a recent analysis of HLA and PTPN22 alleles (27) and
suggests that epistasis is unlikely to be a major contributor
to the familial clustering in type 1 diabetes.
Implications. This largest and most robustly powered
linkage study of type 1 diabetes found no loci with genome-
wide signiﬁcant linkage beyond those in the major histo-
compatibility complex (HLA)a n dINS. The absence of ad-
ditional major loci also suggests that the remaining genetic
susceptibility (missing heritability) may well reside in many
other non-HLA genes, each contributing such a low risk that
it escapes detection by linkage even in as large a sample
collection as in this study. Importantly, it seems unlikely
that the remaining familial clustering is a result of major loci
with complex variants not tagged by current SNP maps or
by such loci with multiple rare moderate-effect variants.
As previously identiﬁed by the T1DGC GWAS, numerous
genes contribute to type 1 diabetes risk yet these have
relatively small individual effects. It should be emphasized,
however, that the size of the effect does not correlate with
the potential importance of the gene in a critical pathway
or therapeutic target. By comparison with the NOD mouse
model, an individual locus may have a small effect but
could nevertheless have a major outcome on disease, as
shown in many studies of congenic strains that differ only
at a single susceptibility locus (e.g., [28,29]).
The remaining genetic variation contributing to type 1
diabetes risk may be determined by numerous other
mechanisms, such as shared intrafamilial environmental
factors, which require different research approaches.
Another mechanism could involve structural (e.g., copy
number) variants not tagged by the current SNP arrays. In
type 1 diabetes, one of the most important risk factors
is the INS variable number of tandem repeats, a copy-
number variant. Other copy-number or structural variants
may contribute to risk; thus, a genome-wide assessment
for these effects is necessary, though our linkage results,
and the recent study of copy-number variants in 2,000
type 1 diabetes cases (30), indicate that a structural var-
iant with a common susceptibility allele with a large
effect is unlikely to exist in the populations studied. An-
other mechanism is the contribution of low-frequency
sequence susceptibility variants that may cluster in genes
but not occur at the same position in the gene, as ob-
served for IFIH1 (31). However, our linkage results sug-
gest that genes with multiple rare variants with high
disease penetrance are not a major contributor to the
inheritance of type 1 diabetes. The T1DGC families were
recruited for detection of major gene linkage effects and
are among the most appropriate resources for future
studies addressing the effects of structural variants and
rare variants on type 1 diabetes risk.
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